Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review [0.03%]
绝经后ER阳性非转移性乳腺癌患者接受辅助内分泌治疗对生活质量的纵向影响：系统综述
Hong Xiao,Xinyi Jiang,Cheng Chen et al.
Hong Xiao et al.
Background: Anti-estrogen (ER) endocrine therapy is an effective treatment strategy in reducing breast cancer mortality. This therapy has a better therapeutic index than chemotherapy but can still affect patients' quality...
Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data [0.03%]
比较用于治疗多发性硬化的疾病修正疗法：来自美国保险索赔数据的卫生保健资源利用率和复发率分析
Jacqueline Nicholas,Aaron Boster,Ning Wu et al.
Jacqueline Nicholas et al.
Background: Data on comparative healthcare resource utilization and costs associated with the newer oral disease-modifying therapies (DMTs) for managing relapsing-remitting multiple sclerosis (MS) in routine clinical prac...
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants [0.03%]
评估预防早产儿呼吸道合胞病毒所需帕利珠单抗成本的差异
Ahva Shahabi,Desi Peneva,Devin Incerti et al.
Ahva Shahabi et al.
Background: The variability in cost of palivizumab treatment, indicated for prevention of respiratory syncytial virus (RSV) infections in high-risk infants, has not been robustly estimated in prior studies. This study aim...
An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients' Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners [0.03%]
长期等候接受代谢及减肥手术病人的生命质素(术前及术后一年)——对医疗计划者的启示:一个试探性研究
Julie A Campbell,Martin Hensher,Amanda Neil et al.
Julie A Campbell et al.
Background: Long-term publicly waitlisted bariatric surgery patients typically experience debilitating physical/psychosocial obesity-related comorbidities that profoundly affect their quality of life. ...
Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire [0.03%]
希腊偏头痛致残量表(MIDAS)问卷的可靠性和有效性
Theodora Oikonomidi,Michail Vikelis,Artemios Artemiadis et al.
Theodora Oikonomidi et al.
Background: The Migraine Disability Assessment (MIDAS) Questionnaire is a reliable and valid instrument for migraine-related disability. Such a tool is needed to quantify migraine-related disability in the Greek populatio...
Weighting Health Outcomes by Socioeconomic Position Using Stated Preferences [0.03%]
运用主观评价法按社会经济地位对健康结果进行加权研究
Anita Lal,Mohammad Siahpush,Marjory Moodie et al.
Anita Lal et al.
Background: The trade-off that society is willing to make to promote a more equitable distribution of health can be represented as a social welfare function (SWF). SWFs are an economic construct that can be used to illust...
Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward [0.03%]
印度卫生技术评估的现状及未来展望：政策制定方面的应用
Shankar Prinja,Laura E Downey,Vijay K Gauba et al.
Shankar Prinja et al.
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada [0.03%]
贝伐单抗治疗加拿大铂耐药复发性卵巢癌的经济评估
Graeme Ball,Feng Xie,Jean-Eric Tarride
Graeme Ball
Background: Ovarian cancer is a leading cause of cancer-related mortality. Although the disease is relatively rare, it carries a disproportionately large morbidity burden. ...
Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review [0.03%]
离散选择试验方法在烟草控制领域中的应用：系统综述
Kabindra Regmi,Dinesh Kaphle,Sabina Timilsina et al.
Kabindra Regmi et al.
Background: Economic evidence relating to tobacco control is generally derived from the cost effectiveness of smoking-cessation programs or the economic impact of tobacco-induced disease, based on revealed-preference data...
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease [0.03%]
哪些成本重要？稳定型冠心病经济评价中纳入的成本及其对决策不确定性的的影响
James Lomas,Miqdad Asaria,Laura Bojke et al.
James Lomas et al.
Background: Variation exists in the resource categories included in economic evaluations, and National Institute for Health and Care Excellence (NICE) guidance suggests the inclusion only of costs related to the index con...